Cambium Bio Ltd has released a press release.
Cambium Bio Raises A$1.0 Million via Placement
Earlier from Cambium Bio
- FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
- Half Year Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- Cambium Bio Secures A$2.4 Million Strategic Investment